|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||
| Cash | |||||||||||||
| Prepaid expenses | |||||||||||||
| Other current assets | |||||||||||||
| Extension deposits due from Sponsor | |||||||||||||
| Total current assets | |||||||||||||
| Cash (investments) held in Trust Account | |||||||||||||
| Other non-current assets | |||||||||||||
| Total Assets | |||||||||||||
| LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS' DEFICIT | |||||||||||||
| Current liabilities: | |||||||||||||
| Accounts payable | |||||||||||||
| Accrued expenses | |||||||||||||
| Total current liabilities | |||||||||||||
| Deferred underwriting fees payable | |||||||||||||
| Convertible loan from related party | |||||||||||||
| Total liabilities | |||||||||||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 1,500,000 and 4,059,402 shares at $11.55 and 10.91 per share at September 30, 2024 and December 31, 2023, respectively | |||||||||||||
| Common Class A | |||||||||||||
| Total class A ordinary shares subject to possible redemption, $0.0001 par value; 1,500,000 and 4,059,402 shares at $11.55 and 10.91 per share at September 30, 2024 and December 31, 2023, respectively | |||||||||||||
| Shareholders' deficit | |||||||||||||
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding | |||||||||||||
| Common stock - $0.0001 par value | |||||||||||||
| Common Class A | |||||||||||||
| Class B Ordinary Shares | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total shareholders' deficit | |||||||||||||
| Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders' Deficit | |||||||||||||
Loading...
